Latent transforming growth factor β-binding protein 4 is downregulated in esophageal cancer via promoter methylation.
Latent transforming growth factor β-binding protein 4 (LTBP4) is an extracellular matrix molecule that is a member of important connective tissue networks and is needed for the correct folding and the secretion of TGF-β1. LTBP4 is downregulated in carcinomas of various tissues. Here we show that LTB...
Guardado en:
Autores principales: | Insa Bultmann, Anne Conradi, Celine Kretschmer, Anja Sterner-Kock |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b9ce7702860649d8ba8054f2bd047482 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Silencing DACH1 promotes esophageal cancer growth by inhibiting TGF-β signaling.
por: Liang Wu, et al.
Publicado: (2014) -
Nicotine-mediated OTUD3 downregulation inhibits VEGF-C mRNA decay to promote lymphatic metastasis of human esophageal cancer
por: Meng Wang, et al.
Publicado: (2021) -
The RBP-Jκ binding sites within the RTA promoter regulate KSHV latent infection and cell proliferation.
por: Jie Lu, et al.
Publicado: (2012) -
Downregulation of miR-135b-5p Suppresses Progression of Esophageal Cancer and Contributes to the Effect of Cisplatin
por: Yuzhu Di, et al.
Publicado: (2021) -
Corrigendum: Downregulation of miR-135b-5p Suppresses Progression of Esophageal Cancer and Contributes to the Effect of Cisplatin
por: Yuzhu Di, et al.
Publicado: (2021)